What Apira Science does

Apira Science, Inc. is a privately held US medical device manufacturer (founded circa 2004-2006, headquartered in Boca Raton, Florida) that develops and sells consumer Low-Level Laser Therapy (LLLT) products for hair regrowth and skin rejuvenation. The company's core technology uses laser diodes and LEDs emitting at 655nm wavelength housed in wearable devices, delivering controlled irradiance doses (e.g., 67 J/cm2 per 25-minute session) to stimulate cellular activity in hair follicles and dermal tissue. The product portfolio spans three sub-brands: iGrow (FDA-cleared laser helmet for androgenic alopecia, launched 2011), iDerma (LED skincare masque launched 2017), and GroWell (next-generation CE-approved hair regrowth cap launched 2025). The business generated a reported 300,000+ cumulative customers across more than 15 years of operation.

The company monetizes exclusively through direct-to-consumer hardware sales of its devices, complemented by a small line of consumable add-ons including 5% Minoxidil treatment, shampoo, conditioner, hair supplements, thickening serum, and a scalp massager. Distribution runs through company-owned e-commerce storefronts (growellcap.com, idermaskincare.store), the Amazon marketplace, and potentially third-party retailers; there is no clinical/professional channel or B2B institutional sales motion. Marketing emphasizes clinical credibility — specifically peer-reviewed double-blind RCTs demonstrating 35-37% hair count increases in 16 weeks — rather than performance advertising, with FDA clearance, CE approval, and patent portfolio (major utility patents on hair and skin phototherapy) serving as the primary demand drivers. The target customer base is individual adult men and women with androgenic alopecia or age-related skin concerns seeking non-invasive, non-pharmaceutical treatment alternatives.

Apira Science's defensibility rests on its clinical evidence base, regulatory clearances (FDA 510(k) and CE Mark), and patent portfolio rather than scale or recurring software revenue. The company appears to operate as a small, founder-controlled niche operator: headcount is reported at 11-50 employees, no funding rounds are disclosed, no M&A or partnership activity is referenced, and no leadership changes are documented. The addressable market is favorable — laser hair loss treatment is projected at 12.0% CAGR through 2031 within a hair restoration services market growing from $7.53B (2025) to $12.52B (2031) — but the company's revenue capture within that market remains undisclosed, positioning it as a stable sub-scale player with a defensible but limited growth ceiling absent external capital or strategic action.

Name

Apira Science

Legal name

Apira Science, Inc.

Website

https://apirascience.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Apira Science is a privately held US medical device manufacturer that develops and sells consumer Low-Level Laser Therapy (LLLT) devices under the iGrow, GroWell, and iDerma brands for hair regrowth and skin rejuvenation, sold direct-to-consumer via e-commerce and Amazon.

Ownership category

akta.pro rank

Product category

Consumer Phototherapy Devices

NAICS

Toilet Preparation Manufacturing (325620)

SIC

Surgical & Medical Instruments & Apparatus (3841), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Laser & Energy-Based Dermatology (HLAKACAF)

akta.pro secondary industry

Conditioners & Hair Masks (CRABABAB)

Keywords

• Low-level laser therapy
• LLLT hair regrowth
• LED light therapy devices
• Phototherapy hair growth
• Laser hair restoration

Headquarters

HQ city

Boca Raton

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Hardware Product Sales: One-time sale of LLLT devices (helmets, caps) and complementary hair care products (shampoo, conditioner, supplements, serums). Primary revenue from consumer device purchases with optional ancillary product sales.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Apira Science designs, manufactures, and sells Low-Level Laser Therapy (LLLT) devices for hair regrowth and skin rejuvenation. Its portfolio includes the iGrow laser helmet, the GroWell hair regrowth cap, and the iDerma LED skincare masque, supported by FDA clearance, peer-reviewed clinical trials, and proprietary utility patents on hair and skin phototherapy. Products are sold direct-to-consumer via company-owned e-commerce sites and Amazon.

Product overview

Apira Science is a medical device manufacturer with 20+ years of expertise in Low-Level Laser Therapy (LLLT) for hair regrowth and skin rejuvenation. The company offers a portfolio of phototherapy devices including iGrow (laser helmet), GroWell (stylish hair regrowth cap), and iDerma (LED light skincare masque), all leveraging LLLT technology at 655nm wavelengths. GroWell represents the next evolution with fashion-forward design, while iGrow maintains clinical credibility with FDA clearance and published peer-reviewed trials. The product line is complemented by hair care support products including shampoo, conditioner, minoxidil treatment, supplements, serum, and scalp massager. The company holds major utility patents on hair and skin phototherapy applications and sponsors award-winning clinical research in LLLT-mediated hair growth.

Differentiator

Problem solved

Functional benefit

Brands

• GroWell: Hair regrowth cap combining fashion-forward design with LLLT laser technology for treating hair thinning and loss.
• iGrow
• iDerma

Products and services

• GroWell Hair Regrowth Cap Wearable hair regrowth cap using Low-Level Laser Therapy (LLLT) with strategic laser coverage and optimized light intensity, designed for at-home treatment of hair thinning and androgenic alopecia. Targets individual men and women seeking a non-invasive alternative to surgery or drugs.
• iGrow2 Hair Growth Laser System Wearable helmet containing 21 laser diodes and 30 LED lasers operating at 655nm, delivering LLLT for at-home treatment of androgenic alopecia. FDA cleared for treating genetic hair loss in men and women, with clinical trials demonstrating 35-37% hair count increases in 16 weeks.
• iDerma Youth Restoring Masque LED light therapy mask that uses red and infrared LEDs to penetrate skin layers, stimulating cell growth and collagen production. Designed for at-home anti-aging use to reduce fine lines, wrinkles, and improve skin texture and tone. Technology originally developed with NASA and NIH research.
• Revage 670 Apira Science's first hair regrowth laser product, representing the company's initial entry into LLLT-based hair growth devices for consumers experiencing hair thinning and loss.

Quantifiable outcome

• 35% average increase in hair growth for men in 16 weeks
• +3 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Dr. Dennis Gross Skincare: Dr. Dennis Gross is an emerging player in at-home LED light therapy masks (Dr. Dennis Gross SpectraLite) that directly competes with Apira's iDerma in the red-light facial rejuvenation category.
• CurrentBody: CurrentBody is an emerging player in LED/light-therapy beauty devices, including skincare masks and hair growth tools, directly comparable to Apira's iDerma masque in the consumer red-light skincare category.
• Nutrafol: Nutrafol is a hair growth supplement brand that addresses the same hair thinning/loss customer as Apira via the nutraceutical route, overlapping with Apira's GroWell Hair Health Support Supplements.

Direct peers

• Capillus: Capillus sells laser caps for hair regrowth under the same FDA-cleared LLLT category as Apira's iGrow/GroWell, with overlapping channels including D2C and professional/clinical sales to hair restoration clinics.
• iRestore: iRestore is a direct LLLT laser hair growth device competitor selling FDA-cleared helmets and caps through D2C and Amazon, overlapping Apira's core iGrow/GroWell value proposition.
• HairMax: HairMax is a direct competitor in consumer LLLT laser hair growth devices (laser bands, caps, and helmets) targeting the same male and female androgenic alopecia customer that Apira serves with iGrow and GroWell.
• Theradome: Theradome produces FDA-cleared LLLT laser helmets for hair loss, directly comparable to Apira's iGrow helmet in technology (laser diode helmets) and target customer.

Broad incumbents

• Rogaine: Rogaine is a broad incumbent in hair regrowth (5% minoxidil) sold OTC in mass retail, competing with the minoxidil portion of Apira's GroWell ancillary line as the dominant consumer brand in that molecule.
• Venus Concept: Venus Concept is a broad incumbent in professional aesthetic medical devices (laser hair restoration, skin rejuvenation) that competes with Apira from the clinical/professional channel side, not consumer D2C.

Others

• Cynosure (Hologic): Cynosure is a broad incumbent in energy-based aesthetic devices (laser hair removal, skin rejuvenation) used by dermatologists and med-spas, with adjacent technology to Apira's LLLT platform but sold through professional rather than consumer channels.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/igrowlaser
• Facebookfacebook.com/igrowlaser
• LinkedInlinkedin.com/company/apira-science-inc.

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Apira Science